Dominik Escher

Dominik Escher is the founder of ESBATech, a Novartis Co. GmbH, serving as Managing Director & VP-Research & Development from 2011 to 2012, founded in 1998.
Dr. Escher is the founder of CDR-Life AG, serving as Chairman since 2017, founded in 2017.
Dr. Escher currently works at Eyevensys SAS as Director since 2020.
Dr. Escher currently works at Topadur Pharma AG as Director since 2018.
Dr. Escher currently works at NovaGo Therapeutics AG as Director since 2019.
Dr. Escher currently works at Araris Biotech AG as Director since 2020.
Dr. Escher currently works at Pureos Partners AG as Managing Partner since 2017.
Former jobs include Non-Executive Vice Chairman at Revolo Biotherapeutics Ltd., Director at Cell Medica Switzerland AG, Director & Vice President at Swiss Biotech Association, Vice President-Research & Development at Alcon AG, Principal at The University of California, San Francisco, and Member-Biologics Leadership Team at Novartis Institutes for Biomedical Research, Inc. Education includes a graduate degree and a doctorate from the University of Zurich, conferred in 1995 and 1999 respectively, and a graduate degree from the Swiss Federal Institute of Technology, conferred in 1992.